You are here
- Home
- Therapy Areas
- Cardiovascular
A double-blind, randomised, single-centre, placebo-controlled, cross-over phase I study to investigate renal function in healthy male subjects, after repeated oral dosing of 3 mg AZ 242
- Disease
- diabetes mellitus
- Drug Name
- Galida
- Generic Name
- tesaglitazar
- Sponsor
- AstraZeneca
- Drug Status
- Discontinued
- Phase
- I
- Start Date
- Aug 27, 2002
- Study Name
- SH-SBC-0022
- Study Id
- SH-SBC-0022
- ClinicalTrials.gov ID
- Not Applicable
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
